Graphique du cours de l'action NRSN
NRSN Dividendes
Neurosense Therapeutics Ltd
$0.89
-5.46%
$-0.05
À la fermeture : May 06, 16:00:00 GMT-4
$0.86
-4.19%
$-0.03
Post-Marché: May 06, 20:00:00 GMT-4
Retour
Neurosense Therapeutics Ltd (NRSN) Dividendes
Statistiques clés
Clôture préc.
$0.9498
Prix d'ouverture
$0.9759
Plage de la journée
$0.8005 - $0.9759
Plage de 52 semaines
$0.63 - $2.6
Volume
445.1K
Volume moyen
203.7K
Rendement en dividend
--
BPA (TTM)
-0.62
Capitalisation boursière
$30.4M
Qu’est-ce que NRSN ?
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Fonctionnalités
© 2026 Edgen fonctionné par
